Roche unveils new analytical units for cobas pro integrated solutions in countries accepting CE mark Ruchika Sharma25 Jun 2024 11:30 AM ISTBasel: Roche has announced the launch of its new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in...
Roche gets USFDA nod for chronic blood disorder treatment Crovalimab Ruchika Sharma23 Jun 2024 4:30 PM ISTRoche has received approval from the U.S. Food and Drug Administration (USFDA) for Crovalimab for the treatment of chronic blood...
Roche unveils new highly-sensitive B-cell lymphoma test Ruchika Sharma21 Jun 2024 1:45 PM ISTBasel: Roche has announced the launch of the clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda...
CDSCO Panel Rejects Roche Products India local Phase III CT waiver proposal for Atezolizumab injection SC route Dr. Divya Colin18 Jun 2024 6:00 PM ISTNew Delhi: Recommending to conduct a phase III study in the Indian population to establish the safety and efficacy, the Subject Expert Committee (SEC)...
CDSCO Panel approves Roche's Protocol Amendment proposal to study Entrectinib Dr. Divya Colin12 Jun 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
USFDA grants Emergency Use Authorization for Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV Ruchika Sharma10 Jun 2024 3:26 PM ISTBasel: Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)for its cobas liat...
Roche Alecensa gets European Commission nod as targeted adjuvant treatment for ALK-positive early-stage lung cancer Ruchika Sharma10 Jun 2024 10:00 AM ISTBasel: Roche announced today that the European Commission has approved Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour...
Roche Inavolisib gets USFDA priority review for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Ruchika Sharma29 May 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application and granted Priority...
Head of Roche Pharma Partnering James Sabry to retire Ruchika Sharma27 May 2024 3:30 PM ISTBasel: Roche has announced that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company.James...
Roche gets USFDA Breakthrough Therapy Designation for Inavolisib for breast cancer with mutation Ruchika Sharma21 May 2024 2:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an...
FDA approves new self collection test for screening human papillomavirus Dr. Kamal Kant Kohli20 May 2024 5:45 AM ISTThe US FDA has approved a new self-collection test to detect human papillomavirus (HPV) and identify women at risk for cervical cancer. The new test...
USFDA approves Roche HPV self-collection solution in US Ruchika Sharma15 May 2024 1:05 PM ISTBasel: Roche has announced the FDA approval of its human papillomavirus (HPV) self-collection solution, one of the first available in the United...
